A 2006 PLoS Biology study partitioned peripheral tolerance to a persistent systemic self-antigen into cell-intrinsic and cell-extrinsic components: adoptively transferred autoreactive CD4+ T cells that adaptively tune their antigen responsiveness still chronically help B cells and cause autoantibody-associated arthritis in lymphopenic hosts, whereas T cell-replete hosts stay healthy because host T cells slowly delete the autoreactive cells and block their effector differentiation. The study left three mechanistic questions open. One — the cellular basis of the slow deletion — was later answered by the same laboratory: rare 'deletor' CD4+ T cells outcompete autoreactive targets for shared sub-threshold self peptide-MHC ligands. The two surviving questions define this problem: (1) the effector pathway of the arthritis in the adaptively tolerant lymphopenic setting, where B cells are required yet, in the source's preliminary and unpublished experiments, transfer of serum from arthritic mice did not induce arthritis in the recipients, so the necessity and sufficiency of autoantibodies versus antibody-independent B cell function versus nonhumoral T cell effector mechanisms remains unresolved; and (2) the generality of adaptive tuning versus extrinsic regulation in tolerance to persisting antigen, which the source recommended testing in chronic infection models (e.g., persistent LCMV) with adoptive transfer designs that remove thymic output and trans-regulatory cells — an experiment the subsequent exhaustion literature has not performed in this form.

Background

Peripheral tolerance is the set of mechanisms that keep mature T cells in check after they leave the thymus, where self-reactive clones have already been partially removed. Three processes are classically invoked: anergy (a cell-intrinsic state of unresponsiveness), clonal deletion (physical elimination of the reactive cells), and regulation (suppression by other lymphocytes, notably CD25+ Foxp3+ regulatory T cells). 'Adaptive tolerance' is a particular form of anergy in which a T cell calibrates — tunes down — the sensitivity of its T cell antigen receptor (TCR) and its cytokine output to the ambient level of persistent antigen; building on their earlier demonstration that the depth of this tuning scales with the strength of persistent stimulation (Singh and Schwartz, 2003), this quantitative calibration is also called receptor tuning.

Singh, Chen and Schwartz (2006) dissected these processes in an adoptive transfer system. Naive CD4+ T cells from 5C.C7 TCR transgenic mice — whose receptor recognizes a peptide of moth/pigeon cytochrome c bound to the MHC class II molecule I-E^k — were transferred into mPCC transgenic mice, which express a membrane-bound pigeon cytochrome c as a systemic self-antigen (the transgene drives expression in B cells among other compartments). Recipients were either T cell-deficient (CD3ε−/−; lymphopenic, meaning abnormally low lymphocyte counts, but B cell-replete) or immunocompetent and T cell-replete. In lymphopenic antigen-expressing hosts the transferred cells first expanded, then entered adaptive tolerance (sharply reduced interleukin-2 production and proliferation) but persisted indefinitely. Strikingly, these 'adapted' cells still provided chronic help to B cells — through CD40-CD40L interactions and cytokines — driving polyclonal hypergammaglobulinemia (elevated antibodies of mixed specificities), autoantibodies against DNA, histones and glucose-6-phosphate isomerase, and a mild but scorable arthritis with joint swelling and bone deformation. In T cell-replete hosts the same tuning occurred, but the autoreactive cells additionally underwent a slow deletion (approximately 3.5% of the expanded population lost per day, starting at day 4), failed to differentiate toward effector function, and neither autoantibodies nor arthritis appeared. The paper thus partitioned tolerance into a cell-intrinsic component (tuning), which alone cannot prevent systemic pathology, and a cell-extrinsic component (requiring other host T cells), which deletes the adapted cells and blocks their differentiation.

The authors explicitly left three mechanistic questions open: (i) the cellular nature of the T cell-dependent deletion — a direct T-T interaction, trophic competition, or something else — given that depleting CD25+ cells and 'space filling' with an unrelated TCR transgenic population were both insufficient explanations; (ii) whether the autoantibodies are the necessary and sufficient effectors of the arthritis — B cells were required for the disease (no arthritis in Rag2−/− antigen-expressing recipients for at least 110 days), yet in preliminary experiments reported by the authors as unpublished data, transfer of serum from arthritic mice to Rag2−/− antigen-expressing recipients did not induce arthritis, and the conditions of that transfer (autoantibody titre, isotype and volume transferred, timing, and recipients unable to mount or amplify their own antibody response) were not characterized; and (iii) how generally adaptive tuning, rather than extrinsic regulation, governs tolerance to persisting antigens, with a recommendation that chronic viral infection models (e.g., persistent lymphocytic choriomeningitis virus, LCMV) be revisited with adoptive transfer designs lacking thymic output (the thymus's continuing production of new T cells) and trans-regulatory cells, because such infections superimpose fluctuating antigen loads, innate inflammatory stimuli (e.g., ligands of Toll-like receptors, TLRs) and viral escape variants on any tuning process; the authors also noted that constant fluxes in antigen dose may recruit mechanisms other than tuning to regulate immunopathology.

Subsequent work by the same laboratory answered question (i). Singh, Bando and Schwartz (2012) showed that the slow contraction of antigen-specific CD4+ T cell populations is mediated by relatively rare 'deletor' CD4+ T cells — not conventional regulatory T cells, and not competitors for generic trophic (survival) factors such as cytokines — which outcompete the target cell for recognition of a shared, sub-threshold (weak, non-activating) endogenous peptide-MHC ligand; one such ligand in the 5C.C7 system is the GP peptide of an endogenous retrovirus presented by I-E^k. Transfer of deletor cells prevented the arthritis of lymphopenic antigen-expressing hosts. Related work refined this picture: at low precursor numbers (below about 1000 cells) chronic self-antigen induces anergy without any deletion (Steinert et al., 2012), and the depth of cell-intrinsic tuning itself depends on population density, such that reducing T cell density allows deeper re-tuning that eliminates residual autoimmune pathology (Chuang et al., 2017). In a different systemic-antigen system (ovalbumin-specific cells in antigen-expressing hosts), apoptosis proved dispensable for tolerance, with cell-intrinsic anergy sufficient (Barron et al., 2008) — a useful contrast showing the extrinsic deletion is not a universal requirement. Questions (ii) and (iii), by contrast, have not been directly resolved. Adjacent arthritis models delimit the possibilities — autoreactive CD4+ T cells can cause arthritis with no B cells or antibody at all in a hemagglutinin neo-self-antigen model (Rankin et al., 2008); T cells in the K/BxN glucose-6-phosphate-isomerase model both drive arthritogenic antibodies and, via interleukin-17, augment antibody-induced arthritis independently of antibodies (Jacobs et al., 2009); and Foxp3+ regulatory T cells are needed to anergize arthritogenic T cells in lymphopenic settings (Martinez et al., 2012) — but none of these addresses the effector pathway in the original mPCC/5C.C7 system, and the recommended chronic-infection reexamination has not been performed.

Problem Statement

The problem is the two unresolved components of the 2006 study, tied together by one scientific objective: to complete the mechanistic account of how cell-intrinsic adaptation and cell-extrinsic regulation jointly enforce peripheral tolerance to a persistent antigen — that is, not only what limits the autoreactive clone (answered at the cellular level by the 2012 deletor work), but how pathology actually materializes when extrinsic regulation is absent, and how far the tuning paradigm extends beyond systemic self-antigen.

(1) Effector pathway of the arthritis in adaptively tolerant, lymphopenic hosts. In the mPCC/5C.C7 system, arthritis requires B cells (no disease in Rag2−/− antigen-expressing recipients for at least 110 days), but in the source's preliminary, unpublished experiments passive transfer of serum from arthritic mPCC,CD3ε−/− mice into mPCC,Rag2−/− recipients did not induce arthritis. Identify the causal effector arm: are the T cell-dependent autoantibodies necessary and/or sufficient for joint pathology; if not, do B cells contribute antibody-independently (for example, as the antigen-expressing antigen-presenting compartment that maintains the pathogenic T cell population), and/or do the tuned autoreactive T cells act through nonhumoral routes such as cytokines or recruitment of innate inflammatory cells? The target is to discriminate among these arms in the lymphopenic antigen-expressing host, where no single manipulation is decisive on its own: whether the unpublished serum-transfer negative reflects insufficiency of autoantibody or the conditions of that transfer is itself part of the question, and the plateau levels of 5C.C7 T cells are approximately 4-fold lower in mPCC,Rag2−/− than in mPCC,CD3ε−/− hosts, so B-cell-deficient comparisons carry their own confound.

(2) Intrinsic adaptation versus extrinsic regulation in tolerance to persistent foreign antigen. Following the 2006 recommendation: using adoptive transfer designs that remove thymic output and trans-regulatory cells (the design used for the self-antigen study), determine how tolerance to a persisting antigen — as in chronic LCMV infection, where antigen loads fluctuate, innate stimuli are present, and escape variants arise — is partitioned between T cell-intrinsic tuning and extrinsic regulation. A single chronic-infection exemplar (persistent LCMV) satisfies this component, provided the answer also states which other persisting-antigen settings the partition would be expected to transfer to.

The two components are independently meaningful and address the mechanistic gap the 2006 paper left. Its own conclusion was that at least two distinct mechanisms — one cell-intrinsic and the other in trans — must cooperate to ensure complete peripheral tolerance, and what limits the autoreactive clone has since been answered at the cellular level by the 2012 deletor work; what remains is how pathology materializes when the extrinsic mechanism is absent, and how far the tuning paradigm extends beyond systemic self-antigen.

Both components are part of the problem: each is independently meaningful, but answering either one alone leaves the other open. For each component, the task is to specify experiments that would discriminate among the candidate mechanisms — the manipulations, the predicted readouts, and the inference each readout would license, including how it resolves the confounds named above.

References

  1. Singh NJ, Chen C, Schwartz RH (2006) The Impact of T Cell Intrinsic Antigen Adaptation on Peripheral Immune Tolerance. PLoS Biology 4(11):e340. DOI: 10.1371/journal.pbio.0040340. https://doi.org/10.1371/journal.pbio.0040340
  2. Singh NJ, Schwartz RH (2003) The strength of persistent antigenic stimulation modulates adaptive tolerance in peripheral CD4+ T cells. Journal of Experimental Medicine 198:1107-1117. DOI: 10.1084/jem.20030913. https://doi.org/10.1084/jem.20030913
  3. Singh NJ, Cox M, Schwartz RH (2007) TLR ligands differentially modulate T cell responses to acute and chronic antigen presentation. Journal of Immunology 179:7999-8008. DOI: 10.4049/jimmunol.179.12.7999. https://doi.org/10.4049/jimmunol.179.12.7999
  4. Singh NJ, Bando JK, Schwartz RH (2012) Subsets of nonclonal neighboring CD4+ T cells specifically regulate the frequency of individual antigen-reactive T cells. Immunity 37:735-746. DOI: 10.1016/j.immuni.2012.08.008. https://doi.org/10.1016/j.immuni.2012.08.008
  5. Steinert EM, Schwartz RH, Singh NJ (2012) At low precursor frequencies, the T-cell response to chronic self-antigen results in anergy without deletion. European Journal of Immunology 42:2875-2880. DOI: 10.1002/eji.201242518. https://doi.org/10.1002/eji.201242518
  6. Chuang E, Augustine M, Jung M, Schwartz RH, Singh NJ (2017) Density dependent re-tuning of autoreactive T cells alleviates their pathogenicity in a lymphopenic environment. Immunology Letters 192:61-71. DOI: 10.1016/j.imlet.2017.10.005. https://doi.org/10.1016/j.imlet.2017.10.005
  7. Singh NJ (2016) Self-reactivity as the necessary cost of maintaining a diverse memory T-cell repertoire. Pathogens and Disease 74(7):ftw092. DOI: 10.1093/femspd/ftw092. https://doi.org/10.1093/femspd/ftw092
  8. Rankin AL, Reed AJ, Oh S, Cozzo Picca C, Guay HM, Larkin J, Panarey L, Aitken MK, Koeberlein B, Lipsky PE, Tomaszewski JE, Naji A, Caton AJ (2008) CD4+ T cells recognizing a single self-peptide expressed by APCs induce spontaneous autoimmune arthritis. Journal of Immunology 180:833-841. DOI: 10.4049/jimmunol.180.2.833. https://doi.org/10.4049/jimmunol.180.2.833
  9. Jacobs JP, Wu HJ, Benoist C, Mathis D (2009) IL-17-producing T cells can augment autoantibody-induced arthritis. Proceedings of the National Academy of Sciences USA 106:21789-21794. DOI: 10.1073/pnas.0912152106. https://doi.org/10.1073/pnas.0912152106
  10. Martinez RJ, Zhang N, Thomas SR, Nandiwada SL, Jenkins MK, Binstadt BA, Mueller DL (2012) Arthritogenic self-reactive CD4+ T cells acquire an FR4hiCD73hi anergic state in the presence of Foxp3+ regulatory T cells. Journal of Immunology 188:170-181. DOI: 10.4049/jimmunol.1101311. https://doi.org/10.4049/jimmunol.1101311
  11. Barron L, Knoechel B, Lohr J, Abbas AK (2008) Cutting edge: contributions of apoptosis and anergy to systemic T cell tolerance. Journal of Immunology 180:2762-2766. DOI: 10.4049/jimmunol.180.5.2762. https://doi.org/10.4049/jimmunol.180.5.2762
  12. Noval Rivas M, Weatherly K, Hazzan M, Vokaer B, Dremier S, Gaudray F, Goldman M, Salmon I, Braun MY (2009) Reviving function in CD4+ T cells adapted to persistent systemic antigen. Journal of Immunology 183:4284-4291. DOI: 10.4049/jimmunol.0901408. https://doi.org/10.4049/jimmunol.0901408
  13. Grossman Z, Paul WE (2015) Dynamic tuning of lymphocytes: physiological basis, mechanisms, and function. Annual Review of Immunology 33:677-713. DOI: 10.1146/annurev-immunol-032712-100027. https://doi.org/10.1146/annurev-immunol-032712-100027
  14. Vezys V, Masopust D, Kemball CC, Barber DL, O'Mara LA, Larsen CP, Pearson TC, Ahmed R, Lukacher AE (2006) Continuous recruitment of naive T cells contributes to heterogeneity of antiviral CD8 T cells during persistent infection. Journal of Experimental Medicine 203:2263-2269. DOI: 10.1084/jem.20060995. https://doi.org/10.1084/jem.20060995